Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2013

01-12-2013

Acknowledgement of reviewers 2013

Published in: Breast Cancer Research and Treatment | Issue 3/2013

Login to get access

Excerpt

The Editor, Marc Lippman, and Associate Editors: Laura J. Esserman, Stephen P. Ethier, Stefan Gluck and Kevin S. Hughes, and Springer would like to acknowledge reviewers’ contributions to the journal and offer their thanks. …
Metadata
Title
Acknowledgement of reviewers 2013
Publication date
01-12-2013
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2013
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2790-9

Other articles of this Issue 3/2013

Breast Cancer Research and Treatment 3/2013 Go to the issue

Epidemiology

Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis

Brief Report

Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer

Review

Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998–2002

Brief Report

Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines

Clinical trial

Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients

Epidemiology

Risk of GWAS-identified genetic variants for breast cancer in a Chinese population: a multiple interaction analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits